Skander Mulder

775 total citations · 1 hit paper
9 papers, 565 citations indexed

About

Skander Mulder is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Skander Mulder has authored 9 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Nephrology, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Epidemiology. Recurrent topics in Skander Mulder's work include Chronic Kidney Disease and Diabetes (4 papers), Liver Disease Diagnosis and Treatment (3 papers) and Diabetes Treatment and Management (3 papers). Skander Mulder is often cited by papers focused on Chronic Kidney Disease and Diabetes (4 papers), Liver Disease Diagnosis and Treatment (3 papers) and Diabetes Treatment and Management (3 papers). Skander Mulder collaborates with scholars based in Netherlands, United States and Denmark. Skander Mulder's co-authors include Hiddo J.L. Heerspink, Paul Perco, Johannes Leierer, Michael K. Hansen, Gert Mayer, Andreas Heinzel, Wenjun Ju, Michelle J. Pena, Gozewijn D. Laverman and Pepijn Vemer and has published in prestigious journals such as Diabetologia, Journal of Medical Internet Research and Diabetes Obesity and Metabolism.

In The Last Decade

Skander Mulder

8 papers receiving 558 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease

2019 340 citations Hiddo J.L. Heerspink, Paul Perco et al. Diabetologia profile →

Peers

Skander Mulder

EDM

NEPHR

SURGE

MB

CCM

Chenzhong Li China

Daishiro Yamada Japan

Lyubov Chaykovska Switzerland

Hiroyuki Kadoya Japan

Lijun Zhao China

Berne Yee United States

Daniel P. K. Ng Singapore

Y Nishizawa Japan

Kuolung Hu United States

Agnese Filippello Italy

Chenzhong Li China

Skander Mulder

287 ×0.9

EDM

160 ×0.9

NEPHR

133 ×0.8

SURGE

174 ×1.1

MB

51 ×0.7

CCM

Citations per year, relative to Skander Mulder Skander Mulder (= 1×) peers Chenzhong Li

Countries citing papers authored by Skander Mulder

Since Specialization

Citations

This map shows the geographic impact of Skander Mulder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Skander Mulder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Skander Mulder more than expected).

Fields of papers citing papers by Skander Mulder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Skander Mulder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Skander Mulder. The network helps show where Skander Mulder may publish in the future.

Co-authorship network of co-authors of Skander Mulder

This figure shows the co-authorship network connecting the top 25 collaborators of Skander Mulder. A scholar is included among the top collaborators of Skander Mulder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Skander Mulder. Skander Mulder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Viola, Irene, et al.. (2025). Fashion Beneath the Skin - a Fashion Exhibition Experience in Social Virtual Reality. 1650–1651.

2.

Mulder, Skander, Anja J. Rueten‐Budde, Babette Bais, et al.. (2022). Dynamic Digital Twin: Diagnosis, Treatment, Prediction, and Prevention of Disease During the Life Course. Journal of Medical Internet Research. 24(9). e35675–e35675. 27 indexed citations

3.

Provenzano, Michele, Skander Mulder, Peter Rossing, et al.. (2022). Impact of random variation in albuminuria and estimated glomerular filtration rate on patient enrolment and duration of clinical trials in nephrology. Diabetes Obesity and Metabolism. 24(6). 983–990. 5 indexed citations

4.

Mulder, Skander, Paul Perco, Thomas Hankemeier, et al.. (2020). Baseline urinary metabolites predict albuminuria response to spironolactone in type 2 diabetes. Translational research. 222. 17–27. 11 indexed citations

5.

Mulder, Skander, Ann Hammarstedt, Sunil B. Nagaraj, et al.. (2020). A metabolomics‐based molecular pathway analysis of how the sodium‐glucose co‐transporter‐2 inhibitor dapagliflozin may slow kidney function decline in patients with diabetes. Diabetes Obesity and Metabolism. 22(7). 1157–1166. 46 indexed citations

6.

Heerspink, Hiddo J.L., Paul Perco, Skander Mulder, et al.. (2019). Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease. Diabetologia. 62(7). 1154–1166. 340 indexed citations breakdown →

7.

Mulder, Skander, Hiddo J.L. Heerspink, Manjula Darshi, et al.. (2019). Effects of dapagliflozin on urinary metabolites in people with type 2 diabetes. Diabetes Obesity and Metabolism. 21(11). 2422–2428. 48 indexed citations

8.

Mulder, Skander, Habib Hamidi, Matthias Kretzler, & Wenjun Ju. (2018). An integrative systems biology approach for precision medicine in diabetic kidney disease. Diabetes Obesity and Metabolism. 20(S3). 6–13. 29 indexed citations

9.

Mulder, Skander, H.‐H. Parving, Giuseppe Remuzzi, et al.. (2015). Early renin‐angiotensin system intervention is more beneficial than late intervention in delaying end‐stage renal disease in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 18(1). 64–71. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact